|
|
||||||||


*
Molecular Biology Section, Laboratory of Immunology, National Institute of Allergy and Infectious Diseases and
Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892

TCRs, which use an Ab-like structure to form a combining
site, recognize molecular complexes consisting of peptides bound to MHC
class I (MHC-I) or class II (MHC-II) molecules. To explore the
similarities and differences between Ab and T cell recognition of
similar structures, we have isolated two mAbs, KP14 and KP15, that
specifically bind H-2Dd complexed with an HIV envelope
gp160-derived peptide, P18-I10. These Abs are MHC and peptide specific.
Fine specificity of mAb binding was analyzed using a panel of synthetic
peptides, revealing similarities between the mAb and a cloned TCR with
the same specificity. These two mAbs used the same VH and
JH gene segments, but different D, V
, and J
genes.
Administered in vivo, mAb KP15 blocked the induction of CTL specific
for recombinant vaccinia virus-encoded gp160, indicating its ability to
bind endogenously generated MHC/peptide complexes. Analysis of the fine
specificity of these mAbs in the context of their encoded amino acid
sequences and the known three-dimensional structure of the
H-2Dd/P18-I10 complex suggests that they bind in an
orientation similar to that of the TCR. Thus, the plasticity of the B
cell receptor repertoire and the structural similarities among BCR and
TCR allow Abs to effectively mimic 
TCRs. Such mAbs may be useful
in the therapeutic modulation of immune responses against infectious
agents or harmful self Ags as well as in tracing steps in Ag
processing.
This article has been cited by other articles:
![]() |
A. H. Dzutsev, I. M. Belyakov, D. V. Isakov, D. H. Margulies, and J. A. Berzofsky Avidity of CD8 T cells sharpens immunodominance Int. Immunol., April 1, 2007; 19(4): 497 - 507. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Garcia, K. R. Prabakar, J. Diez, Z. A. Cao, G. Allende, M. Zeller, R. Dogra, A. Mendez, E. Rosenkranz, U. Dahl, et al. Dendritic Cells in Human Thymus and Periphery Display a Proinsulin Epitope in a Transcription-Dependent, Capture-Independent Fashion J. Immunol., August 15, 2005; 175(4): 2111 - 2122. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Laugel, J. M. Boulter, N. Lissin, A. Vuidepot, Y. Li, E. Gostick, L. E. Crotty, D. C. Douek, J. Hemelaar, D. A. Price, et al. Design of Soluble Recombinant T Cell Receptors for Antigen Targeting and T Cell Inhibition J. Biol. Chem., January 21, 2005; 280(3): 1882 - 1892. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Oh, M. Terabe, C. D. Pendleton, A. Bhattacharyya, T. K. Bera, M. Epel, Y. Reiter, J. Phillips, W. M. Linehan, C. Kasten-Sportes, et al. Human CTLs to Wild-Type and Enhanced Epitopes of a Novel Prostate and Breast Tumor-Associated Protein, TARP, Lyse Human Breast Cancer Cells Cancer Res., April 1, 2004; 64(7): 2610 - 2618. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. E. Biddison, R. V. Turner, S. J. Gagnon, A. Lev, C. J. Cohen, and Y. Reiter Tax and M1 Peptide/HLA-A2-Specific Fabs and T Cell Receptors Recognize Nonidentical Structural Features on Peptide/HLA-A2 Complexes J. Immunol., September 15, 2003; 171(6): 3064 - 3074. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Chames, R. A. Willemsen, G. Rojas, D. Dieckmann, L. Rem, G. Schuler, R. L. Bolhuis, and H. R. Hoogenboom TCR-Like Human Antibodies Expressed on Human CTLs Mediate Antibody Affinity-Dependent Cytolytic Activity J. Immunol., July 15, 2002; 169(2): 1110 - 1118. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Chung, I. M. Belyakov, M. A. Derby, J. Wang, L. F. Boyd, J. A. Berzofsky, and D. H. Margulies Competitive Inhibition In Vivo and Skewing of the T Cell Repertoire of Antigen-Specific CTL Priming by an Anti-Peptide-MHC Monoclonal Antibody J. Immunol., July 15, 2001; 167(2): 699 - 707. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, M. C. Whitman, K. Natarajan, J. Tormo, R. A. Mariuzza, and D. H. Margulies Binding of the Natural Killer Cell Inhibitory Receptor Ly49A to Its Major Histocompatibility Complex Class I Ligand. CRUCIAL CONTACTS INCLUDE BOTH H-2Dd AND beta 2-MICROGLOBULIN J. Biol. Chem., January 4, 2002; 277(2): 1433 - 1442. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |